| 1 | Tips and tricks in the prevention and management of vascular complications in TAVI | 0.0 | 2 | Citations (PDF) |
| 2 | Improved diagnostic accuracy of vessel-specific myocardial ischemia by coronary computed tomography angiography (CCTA) | 1.6 | 5 | Citations (PDF) |
| 3 | Prognostic impact of different triggers in patients with Takotsubo syndrome and chronic obstructive pulmonary disease. Author's reply | 2.3 | 2 | Citations (PDF) |
| 4 | Very low-calorie ketogenic diet reduces central blood pressure and cardiometabolic risk in post-menopausal women with essential hypertension and obesity: a single-center, prospective, open-label, clinical study | 2.2 | 7 | Citations (PDF) |
| 5 | Reevaluating hypoxia and cancer as determinants of prognosis in COPD and Takotsubo syndrome. Author's reply | 2.3 | 0 | Citations (PDF) |
| 6 | The Year in Cardiovascular Medicine 2024: the top 10 papers in interventional cardiology | 2.6 | 1 | Citations (PDF) |
| 7 | Effect of TAVI on Epicardial Functional Indices and Their Relationship to Coronary Microvascular Function | 3.2 | 10 | Citations (PDF) |
| 8 | Monitoring the Effects of Cardiac Rehabilitation Programs in Heart Failure Patients: The Role of Biomarkers | 1.4 | 4 | Citations (PDF) |
| 9 | Mastering percutaneous coronary intervention in calcified coronary lesions with optical coherence tomography: the path to optimal outcomes | 2.6 | 1 | Citations (PDF) |
| 10 | Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) | 8.1 | 20 | Citations (PDF) |
| 11 | Predicting takotsubo syndrome subtypes: An interpretable machine learning model for differentiating emotional versus physical aetiologies | 1.6 | 4 | Citations (PDF) |
| 12 | Strategies for a patient with severe aortic stenosis affected by appendage thrombosis, atrial fibrillation and coronary artery disease to undergo TAVI | 1.2 | 0 | Citations (PDF) |
| 13 | Effects of ticagrelor and prasugrel on coronary microcirculation in elective percutaneous coronary interventionHeart, 2024, 110, 115-121 | 2.6 | 6 | Citations (PDF) |
| 14 | 2023 ESC Guidelines for the management of acute coronary syndromes | 0.9 | 249 | Citations (PDF) |
| 15 | International evaluation of an artificial intelligence–powered electrocardiogram model detecting acute coronary occlusion myocardial infarction | 2.5 | 139 | Citations (PDF) |
| 16 | Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF | 2.7 | 50 | Citations (PDF) |
| 17 | Predictors of percutaneous coronary intervention derived from CCTA in patients with chronic coronary syndrome | 1.6 | 4 | Citations (PDF) |
| 18 | Post-COVID Postural Orthostatic Tachycardia Syndrome and Inappropriate Sinus Tachycardia in the Pediatric Population | 2.6 | 9 | Citations (PDF) |
| 19 | Asymptomatic Aortic Stenosis: From Risk Stratification to Treatment | 1.5 | 6 | Citations (PDF) |
| 20 | Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization | 0.2 | 3 | Citations (PDF) |
| 21 | The year in cardiovascular medicine 2023: the top 10 papers in interventional cardiology | 2.6 | 1 | Citations (PDF) |
| 22 | Impact of pre-admission physical activity on benefits of physiology-guided complete revascularization in older patients with myocardial infarction: insights from the FIRE trial | 1.5 | 10 | Citations (PDF) |
| 23 | Routine Evaluation of Microvascular Dysfunction During Diagnostic Coronary Angiography | 1.9 | 0 | Citations (PDF) |
| 24 | Giant coronary aneurysm and acute myocardial infarction: clinical case report and literature review | 1.4 | 2 | Citations (PDF) |
| 25 | Remembering our friend Jean-Philippe Collet: a giant in cardiology, a gentleman in life | 1.1 | 1 | Citations (PDF) |
| 26 | Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Incident Cancer | 0.6 | 2 | Citations (PDF) |
| 27 | Systematic Review Article: New Drug Strategies for Treating Resistant Hypertension—the Importance of a Mechanistic, Personalized Approach | 1.4 | 19 | Citations (PDF) |
| 28 | Acute Kidney Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: The Role of Vascular Access Site | 1.8 | 3 | Citations (PDF) |
| 29 | Revisión sistemática y metanálisis de estudios aleatorizados y no aleatorizados sobre revascularización guiada por reserva fraccional de flujo | 0.9 | 0 | Citations (PDF) |
| 30 | Ten‐Year Outcome of Recanalization or Medical Therapy for Concomitant Chronic Total Occlusion After Myocardial Infarction | 3.1 | 16 | Citations (PDF) |
| 31 | Prognostic Value of Microvascular Resistance Reserve Measured Immediately After PCI in Stable Coronary Artery Disease | 3.2 | 17 | Citations (PDF) |
| 32 | Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis | 2.6 | 24 | Citations (PDF) |
| 33 | Natural History of Coronary Atherosclerosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: The Role of Quantitative Flow Ratio | 3.2 | 6 | Citations (PDF) |
| 34 | Gut Microbiota Dysbiosis and Sleep Disorders: Culprit in Cardiovascular Diseases | 1.8 | 19 | Citations (PDF) |
| 35 | Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases | 1.4 | 28 | Citations (PDF) |
| 36 | Hybrid coronary revascularization: position paper of the European Society of Cardiology Working Group on Cardiovascular Surgery and European Association of Percutaneous Cardiovascular Interventions | 1.2 | 19 | Citations (PDF) |
| 37 | Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines | 2.6 | 38 | Citations (PDF) |
| 38 | Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines | 13.1 | 31 | Citations (PDF) |
| 39 | Hormonal Balance and Cardiovascular Health: Exploring the Interconnection between Menopause, Body Composition, and Thyroid Function in a Cohort of Hypertensive Women | 1.6 | 5 | Citations (PDF) |
| 40 | PCSK9 Inhibitors: Is the Time Ripe for the “Fast Track” Use Independently on the LDL-C Baseline Values in Acute Coronary Syndrome? | 1.4 | 0 | Citations (PDF) |
| 41 | TCT-291 Impact of Preoperative Quantitative Flow Ratio on Long-Term Coronary Artery Bypass Grafts Patency | 0.7 | 0 | Citations (PDF) |
| 42 | Double Duty: SGLT2 Inhibitors as Cardioprotective and Anticancer Allies | 0.9 | 5 | Citations (PDF) |
| 43 | Gut Microbiome and Carotid Artery Intima-Media Thickness: A Narrative Review of the Current Scenario | 2.2 | 5 | Citations (PDF) |
| 44 | SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) | 8.1 | 65 | Citations (PDF) |
| 45 | Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis | 2.6 | 41 | Citations (PDF) |
| 46 | Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinicsHeart, 2023, 109, 634-642 | 2.6 | 20 | Citations (PDF) |
| 47 | The year in cardiovascular medicine 2022: the top 10 papers in interventional cardiology | 2.6 | 2 | Citations (PDF) |
| 48 | Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group | 2.6 | 146 | Citations (PDF) |
| 49 | Microvascular resistance reserve: a reference test of the coronary microcirculation? | 2.6 | 13 | Citations (PDF) |
| 50 | SARS-CoV-2 Related Myocarditis: What We Know So Far | 1.8 | 10 | Citations (PDF) |
| 51 | Aortic valve bioprostheses: standing the test of time | 1.2 | 0 | Citations (PDF) |
| 52 | 2023 ESC Guidelines for the management of acute coronary syndromes | 2.6 | 4,788 | Citations (PDF) |
| 53 | A novel quantitative flow ratio in coronary bifurcations: a simpler way to a real-time functional provisional stenting strategy | 0.4 | 2 | Citations (PDF) |
| 54 | Comprehensive invasive evaluation of coronary microcirculation in patients with Takotsubo syndrome | 1.9 | 15 | Citations (PDF) |
| 55 | ADDED Index or Percentage Diameter of Residual Coronary Stenosis to Risk-Stratify Patients Presenting With STEMI | 0.4 | 4 | Citations (PDF) |
| 56 | Influence of fractional flow reserve on grafts patency: Systematic review and patient‐level meta‐analysis | 1.1 | 11 | Citations (PDF) |
| 57 | Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography | 1.9 | 70 | Citations (PDF) |
| 58 | Intracoronary pressures to predict myocardial viability in patients with ischemic left ventricular dysfunction | 1.1 | 2 | Citations (PDF) |
| 59 | Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design | 1.8 | 16 | Citations (PDF) |
| 60 | Contemporary Management of Stable Coronary Artery Disease | 1.4 | 36 | Citations (PDF) |
| 61 | Prospective evaluation of the learning curve and diagnostic accuracy for Pre-TAVI cardiac computed tomography analysis by cardiologists in training: The LEARN-CT study | 1.6 | 10 | Citations (PDF) |
| 62 | Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks | 1.1 | 22 | Citations (PDF) |
| 63 | Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta‐Analysis | 3.1 | 217 | Citations (PDF) |
| 64 | Bioresorbable stents: Is the game over? | 1.6 | 19 | Citations (PDF) |
| 65 | Saline-induced coronary hyperemia with continuous intracoronary thermodilution is mediated by intravascular hemolysis | 1.9 | 38 | Citations (PDF) |
| 66 | First report of totally robotically assisted hybrid coronary artery revascularization combining RE‐MIDCAB and R‐PCI: Case report | 0.2 | 2 | Citations (PDF) |
| 67 | Deferral of Coronary Revascularization in Patients With Reduced Ejection Fraction Based on Physiological Assessment: Impact on Long‐Term Survival | 3.1 | 8 | Citations (PDF) |
| 68 | Procedural Outcomes After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease | 3.1 | 41 | Citations (PDF) |
| 69 | Determinants of aortic root dilatation over time in patients with essential hypertension: The Campania Salute Network | 1.5 | 25 | Citations (PDF) |
| 70 | Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) | 2.6 | 45 | Citations (PDF) |
| 71 | Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data | 2.6 | 119 | Citations (PDF) |
| 72 | 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation | 2.6 | 4,436 | Citations (PDF) |
| 73 | Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation | 2.6 | 44 | Citations (PDF) |
| 74 | Invasive Coronary Physiology After Stent Implantation | 1.9 | 38 | Citations (PDF) |
| 75 | Effect of Sex on Outcomes of Coronary Rotational Atherectomy Percutaneous Coronary Intervention (From the European Multicenter Euro4C Registry) | 1.5 | 8 | Citations (PDF) |
| 76 | Contemporary management of calcified coronary lesionsHeart, 2021, 107, 1510-1517 | 2.6 | 3 | Citations (PDF) |
| 77 | Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype | 3.2 | 29 | Citations (PDF) |
| 78 | Changes in surgical revascularization strategy after fractional flow reserve | 1.1 | 2 | Citations (PDF) |
| 79 | Pathophysiology, Diagnosis, and Treatment of Patients with Concomitant Severe Aortic Stenosis and Coronary Artery Disease: A Closer Look to the Unresolved Perplexity | 1.8 | 13 | Citations (PDF) |
| 80 | Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) | 2.6 | 128 | Citations (PDF) |
| 81 | Relationship between peripheral arterial reactive hyperemia and the index of myocardial resistance in patients undergoing invasive coronary angiography | 1.6 | 8 | Citations (PDF) |
| 82 | Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy | 1.8 | 24 | Citations (PDF) |
| 83 | Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pullback pressure gradients | 1.1 | 11 | Citations (PDF) |
| 84 | Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients | 1.6 | 6 | Citations (PDF) |
| 85 | Association of microvascular dysfunction with clinical outcomes in patients with non-flow limiting fractional flow reserve after percutaneous coronary intervention | 0.6 | 8 | Citations (PDF) |
| 86 | Revascularization decisions in patients with chronic coronary syndromes: Results of the second International Survey on Interventional Strategy (ISIS-2) | 1.6 | 27 | Citations (PDF) |
| 87 | Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic Perspectives | 3.2 | 58 | Citations (PDF) |
| 88 | Microvascular Resistance Reserve for Assessment of Coronary Microvascular Function | 0.7 | 217 | Citations (PDF) |
| 89 | Exercise Training: The Holistic Approach in Cardiovascular Prevention | 1.4 | 18 | Citations (PDF) |
| 90 | Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve | 1.6 | 61 | Citations (PDF) |
| 91 | Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial | 1.1 | 12 | Citations (PDF) |
| 92 | FFRCT and CT perfusion: A review on the evaluation of functional impact of coronary artery stenosis by cardiac CT | 1.6 | 35 | Citations (PDF) |
| 93 | Fractional flow reserve in patients with reduced ejection fraction | 2.6 | 27 | Citations (PDF) |
| 94 | 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes | 2.6 | 6,388 | Citations (PDF) |
| 95 | Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention | 1.6 | 32 | Citations (PDF) |
| 96 | Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials | 2.6 | 89 | Citations (PDF) |
| 97 | Validation of the all-comers design: Results of the TARGET-AC substudy | 1.8 | 1 | Citations (PDF) |
| 98 | The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction | 3.4 | 20 | Citations (PDF) |
| 99 | From fallacies to reality: Focus on fractional flow reserve | 1.6 | 0 | Citations (PDF) |
| 100 | Coronary Artery Bypass Grafting or Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease | 3.2 | 11 | Citations (PDF) |
| 101 | Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial | 1.8 | 45 | Citations (PDF) |
| 102 | A personal tribute to Maurizio Galderisi | 2.6 | 0 | Citations (PDF) |
| 103 | Microvascular impairment associated with percutaneous coronary revascularization: The quest for protective microcirculatory strategies | 1.6 | 1 | Citations (PDF) |
| 104 | Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients | 1.8 | 27 | Citations (PDF) |
| 105 | The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19 | 3.2 | 23 | Citations (PDF) |
| 106 | Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events | 2.8 | 17 | Citations (PDF) |
| 107 | Insulin Resistance the Hinge Between Hypertension and Type 2 Diabetes | 1.4 | 201 | Citations (PDF) |
| 108 | Global Fractional Flow Reserve Value Predicts 5‐Year Outcomes in Patients With Coronary Atherosclerosis But Without Ischemia | 3.1 | 14 | Citations (PDF) |
| 109 | DISENGAGE Registry | 3.2 | 4 | Citations (PDF) |
| 110 | Graft patency and progression of coronary artery disease after CABG assessed by angiography-derived fractional flow reserve | 1.6 | 17 | Citations (PDF) |
| 111 | Assessment of carotid cross-sectional area in hypertensive patients: phenotyping and prognostic validation in The Campania Salute Network | 1.4 | 5 | Citations (PDF) |
| 112 | Clinical Outcomes Following Coronary Bifurcation PCI Techniques | 1.9 | 116 | Citations (PDF) |
| 113 | The impact of the extent of side branch disease on outcomes following bifurcation stenting | 1.1 | 11 | Citations (PDF) |
| 114 | Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment | 5.0 | 24 | Citations (PDF) |
| 115 | Characteristics and Outcomes of Patients Presenting With Hypertensive Urgency in the Office Setting: The Campania Salute Network | 1.0 | 8 | Citations (PDF) |
| 116 | Motorized fractional flow reserve pullback: Accuracy and reproducibility | 1.1 | 6 | Citations (PDF) |
| 117 | Fractional Flow Reserve–Based Coronary Artery Bypass Surgery | 1.9 | 52 | Citations (PDF) |
| 118 | Sustained Safety and Performance of the Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Pooled Outcomes of the BIOSOLVE-II and -III Trials at 3 Years | 0.4 | 36 | Citations (PDF) |
| 119 | Novel Indices of Coronary Physiology | 3.2 | 75 | Citations (PDF) |
| 120 | Modulation of Insulin Sensitivity by Exercise Training: Implications for Cardiovascular Prevention | 1.3 | 89 | Citations (PDF) |
| 121 | Fourth universal definition of myocardial infarction (2018) | 2.6 | 3,677 | Citations (PDF) |
| 122 | Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus | 1.8 | 14 | Citations (PDF) |
| 123 | Second-generation drug-eluting stents versus bare-metal stents in saphenous vein grafts: is the choice more complicated than before? | 0.9 | 1 | Citations (PDF) |
| 124 | Imaging in ESC clinical guidelines: chronic coronary syndromes | 1.1 | 90 | Citations (PDF) |
| 125 | A Genotype-Guided Strategy for Oral P2Y
12
Inhibitors in Primary PCI | 19.4 | 632 | Citations (PDF) |
| 126 | Prognostic Value of QFR Measured Immediately After Successful Stent Implantation | 1.9 | 176 | Citations (PDF) |
| 127 | Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis | 0.7 | 256 | Citations (PDF) |
| 128 | Predictive factors of discordance between the instantaneous wave‐free ratio and fractional flow reserve | 1.1 | 64 | Citations (PDF) |
| 129 | Rational and design of the INtentional COronary revascularization versus conservative therapy in patients undergOing successful peripheRAl arTEry revascularization due to critical limb ischemia trial (INCORPORATE trial) | 1.8 | 3 | Citations (PDF) |
| 130 | 2-Year Clinical Outcomes of an Abluminal Groove–Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent | 1.9 | 19 | Citations (PDF) |
| 131 | The Influence of Aortic Valve Obstruction on the Hyperemic Intracoronary Physiology: Difference Between Resting Pd/Pa and FFR in Aortic Stenosis | 1.3 | 12 | Citations (PDF) |
| 132 | Long-Term Patency of Coronary Artery Bypass Grafts After Fractional Flow Reserve–Guided Implantation | 3.2 | 16 | Citations (PDF) |
| 133 | 279Clinical outcome after coronary bifurcation stenting: a systematic review and network meta-Analysis of PCI bifurcation techniques comprising 5572 patients | 2.6 | 2 | Citations (PDF) |
| 134 | Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data | 2.6 | 201 | Citations (PDF) |
| 135 | Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study | 1.8 | 62 | Citations (PDF) |
| 136 | Mid-term outcomes after percutaneous interventions in coronary bifurcations | 1.6 | 45 | Citations (PDF) |
| 137 | Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging | 1.3 | 20 | Citations (PDF) |
| 138 | Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention | 1.3 | 6 | Citations (PDF) |
| 139 | A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery | 1.9 | 104 | Citations (PDF) |
| 140 | Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: a landmark analysis | 1.1 | 12 | Citations (PDF) |
| 141 | Aortic valve replacement improves survival in severe aortic stenosis with gradient–area mismatch | 1.2 | 2 | Citations (PDF) |
| 142 | Resolving Apparent Inconsistencies Between Area, Flow, and Gradient Measurements in Patients With Aortic Valve Stenosis and Preserved Left Ventricular Ejection Fraction | 1.5 | 0 | Citations (PDF) |
| 143 | Macrophage migration inhibitory factor (MIF) is associated with degree of collateralization in patients with totally occluded coronary arteries | 1.6 | 8 | Citations (PDF) |
| 144 | Catheter-Based Measurements of Absolute Coronary Blood Flow and Microvascular Resistance | 3.2 | 135 | Citations (PDF) |
| 145 | 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation | 2.6 | 8,892 | Citations (PDF) |
| 146 | Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease | 13.1 | 246 | Citations (PDF) |
| 147 | Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses | 13.1 | 80 | Citations (PDF) |
| 148 | Severely calcified coronary stenoses: novel challenges, old remedy | 0.1 | 1 | Citations (PDF) |
| 149 | Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease | 13.1 | 43 | Citations (PDF) |
| 150 | Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel | 1.9 | 20 | Citations (PDF) |
| 151 | Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial | 45.2 | 59 | Citations (PDF) |
| 152 | Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis | 1.9 | 134 | Citations (PDF) |
| 153 | Five-Year Outcomes with PCI Guided by Fractional Flow Reserve | 19.4 | 829 | Citations (PDF) |
| 154 | Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery | 3.2 | 100 | Citations (PDF) |
| 155 | Fractional flow reserve (FFR) as a guide to treat coronary artery disease | 1.1 | 23 | Citations (PDF) |
| 156 | New Volumetric Analysis Method for Stent Expansion and its Correlation With Final Fractional Flow Reserve and Clinical Outcome | 1.9 | 42 | Citations (PDF) |
| 157 | Sex Differences in Adenosine-Free Coronary Pressure Indexes | 1.9 | 16 | Citations (PDF) |
| 158 | From debulking to delivery: sequential use of rotational atherectomy and Guidezilla™ for complex saphenous vein grafts intervention | 1.6 | 3 | Citations (PDF) |
| 159 | Study Design of the Graft Patency After FFR-Guided Versus Angiography-Guided CABG Trial (GRAFFITI) | 1.3 | 12 | Citations (PDF) |
| 160 | 2018 ESC/ESH Guidelines for the management of arterial hypertension | 2.6 | 9,097 | Citations (PDF) |
| 161 | Fractional flow reserveto guide and to assesscoronary artery bypass grafting | 2.6 | 28 | Citations (PDF) |
| 162 | Platelet reactivity in patients carrying the e-NOS G894T polymorphism after a loading dose of aspirin plus clopidogrel | 1.6 | 0 | Citations (PDF) |
| 163 | Saline-Induced Coronary Hyperemia | 3.2 | 76 | Citations (PDF) |
| 164 | Correlation between Angiographic and Physiologic Evaluation of Coronary Artery Narrowings in Patients With Aortic Valve Stenosis | 1.5 | 27 | Citations (PDF) |
| 165 | Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients | 4.7 | 77 | Citations (PDF) |
| 166 | C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP | 2.7 | 8 | Citations (PDF) |
| 167 | Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long‐Term Outcome | 0.3 | 9 | Citations (PDF) |
| 168 | Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free Ratio | 0.7 | 46 | Citations (PDF) |
| 169 | Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation | 3.2 | 143 | Citations (PDF) |
| 170 | Visual and Quantitative Assessment of Coronary Stenoses at Angiography Versus Fractional Flow Reserve | 2.5 | 50 | Citations (PDF) |
| 171 | Diabetes does not impact the diagnostic performance of contrast-based fractional flow reserve: insights from the CONTRAST study | 8.1 | 8 | Citations (PDF) |
| 172 | Comparison of Different Diastolic Resting Indexes to iFR | 0.7 | 191 | Citations (PDF) |
| 173 | P1754Macrophage migration inhibitory factor (MIF) is associated with collateralization degree in patients with occluded coronary arteries | 2.6 | 0 | Citations (PDF) |
| 174 | 2034Angiography versus hemodynamic assessment to predict the natural history of coronary stenoses: a fractional flow reserve versus angiography in multivessel evaluation 2 (FAME 2) substudy | 2.6 | 0 | Citations (PDF) |
| 175 | P2374Continuous thermodilution for the assessment of coronary microvasculature: quantification of coronary blood flow and microvascular resistance | 2.6 | 0 | Citations (PDF) |
| 176 | P497One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions | 2.6 | 0 | Citations (PDF) |
| 177 | P1736Angiographic and hemodynamic modifications of Myocardial Bridge during supine bicycle exercise | 2.6 | 0 | Citations (PDF) |
| 178 | In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR–OCT co-registration study | 0.9 | 6 | Citations (PDF) |
| 179 | Left atrial volume computed by 3D rotational angiography best predicts atrial fibrillation recurrence after circumferential pulmonary vein isolation | 0.9 | 15 | Citations (PDF) |
| 180 | T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients | 1.3 | 7 | Citations (PDF) |
| 181 | State of the art: evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses – from debulking to plaque modification, a 40-year-long journey | 2.2 | 162 | Citations (PDF) |
| 182 | EAPCI registries: a first step towards systematic monitoring of European interventional cardiology practice | 2.2 | 8 | Citations (PDF) |
| 183 | Current trends in structural heart interventions: an overview of the EAPCI registries | 2.2 | 22 | Citations (PDF) |
| 184 | The fractional flow reserve gray zone has never been so narrow | 0.9 | 5 | Citations (PDF) |
| 185 | Antegrade wire escalation for chronic total occlusions in coronary arteries | 0.9 | 14 | Citations (PDF) |
| 186 | Clinical Outcome of Patients with Aortic Stenosis and Coronary Artery Disease Not Treated According to Current Recommendations | 1.3 | 5 | Citations (PDF) |
| 187 | Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment | 1.9 | 152 | Citations (PDF) |
| 188 | The ‘napkin-ring’ constrictive pericarditis | 1.1 | 2 | Citations (PDF) |
| 189 | Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI | 0.7 | 378 | Citations (PDF) |
| 190 | Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography | 1.9 | 580 | Citations (PDF) |
| 191 | Standardization of Fractional Flow Reserve Measurements | 0.7 | 208 | Citations (PDF) |
| 192 | Long Coronary Lesions Treated With Thin Strut Bioresorbable Polymer Drug Eluting Stent: Experience From Multicentre Randomized CENTURY II Study | 0.3 | 15 | Citations (PDF) |
| 193 | A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve | 0.7 | 144 | Citations (PDF) |
| 194 | Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention | 13.1 | 32 | Citations (PDF) |
| 195 | Relationship of asymmetric dimethylarginine (ADMA) with extent and functional severity of coronary atherosclerosis | 1.6 | 30 | Citations (PDF) |
| 196 | Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty | 0.9 | 2 | Citations (PDF) |
| 197 | Significance of Intermediate Values of Fractional Flow Reserve in Patients With Coronary Artery Disease | 13.1 | 141 | Citations (PDF) |
| 198 | Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis | 1.0 | 33 | Citations (PDF) |
| 199 | Impact of Right Atrial Pressure on Fractional Flow Reserve Measurements | 1.9 | 52 | Citations (PDF) |
| 200 | Fractional Flow Reserve–Guided Revascularization in Patients With Aortic Stenosis | 1.5 | 45 | Citations (PDF) |
| 201 | Catheter-based functional metrics of the coronary circulation | 0.8 | 3 | Citations (PDF) |
| 202 | Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial | 2.2 | 70 | Citations (PDF) |
| 203 | Let's talk BIG DATA | 2.2 | 2 | Citations (PDF) |
| 204 | Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach | 3.2 | 8 | Citations (PDF) |
| 205 | The STIB score: a simple clinical test to predict clopidogrel resistance | 0.9 | 16 | Citations (PDF) |
| 206 | Iatrogenic atrial septal defect (iASD) after MitraClip system delivery: The key role of PaO2/FiO2 ratio in guiding post-procedural iASD closure | 1.6 | 22 | Citations (PDF) |
| 207 | Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study | 2.6 | 231 | Citations (PDF) |
| 208 | Single String Technique for Coronary Bifurcation Stenting | 1.9 | 16 | Citations (PDF) |
| 209 | Comparison Among Patients ≥75 Years Having Percutaneous Coronary Angioplasty Using Drug-Eluting Stents Versus Bare Metal Stents | 1.5 | 7 | Citations (PDF) |
| 210 | High platelet reactivity and periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: A significant association beyond definitions | 1.6 | 14 | Citations (PDF) |
| 211 | Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: Results of the MEDCOR trial | 1.9 | 22 | Citations (PDF) |
| 212 | Genetically Determined Platelet Reactivity and Related Clinical Implications | 1.4 | 5 | Citations (PDF) |
| 213 | Intracoronary Adenosine | 1.9 | 122 | Citations (PDF) |
| 214 | Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine | 1.3 | 4 | Citations (PDF) |
| 215 | Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial | 45.2 | 592 | Citations (PDF) |
| 216 | European expert consensus on rotational atherectomy | 2.2 | 345 | Citations (PDF) |
| 217 | A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study | 2.2 | 33 | Citations (PDF) |
| 218 | Revascularization Decisions in Patients With Stable Angina and Intermediate Lesions | 3.2 | 165 | Citations (PDF) |
| 219 | Impact of Alpha- and Beta-Adrenergic Receptor Blockers on Fractional Flow Reserve and Index of Microvascular Resistance | 1.3 | 16 | Citations (PDF) |
| 220 | ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation | 1.1 | 36 | Citations (PDF) |
| 221 | α
2A
-Adrenergic Receptor Polymorphism Potentiates Platelet Reactivity in Patients With Stable Coronary Artery Disease Carrying the Cytochrome P450 2C19*2 Genetic Variant | 4.3 | 6 | Citations (PDF) |
| 222 | Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus | 1.9 | 19 | Citations (PDF) |
| 223 | Bioresorbable coronary scaffolds: a novel device-based solution in search of its clinical need | 2.6 | 10 | Citations (PDF) |
| 224 | Prognostic Value of Fractional Flow Reserve | 0.7 | 610 | Citations (PDF) |
| 225 | The Age, Creatinine, and Ejection Fraction Score to Risk Stratify Patients Who Underwent Percutaneous Coronary Intervention of Coronary Chronic Total Occlusion | 1.5 | 35 | Citations (PDF) |
| 226 | Fractional Flow Reserve Calculation From 3-Dimensional Quantitative Coronary Angiography and TIMI Frame Count | 1.9 | 352 | Citations (PDF) |
| 227 | A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial | 2.6 | 158 | Citations (PDF) |
| 228 | Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses | 2.6 | 313 | Citations (PDF) |
| 229 | Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease | 19.4 | 1,022 | Citations (PDF) |
| 230 | Advances in Induced Pluripotent Stem Cells, Genomics, Biomarkers, and Antiplatelet Therapy Highlights of the Year in JCTR 2013 | 1.3 | 3 | Citations (PDF) |
| 231 | Impact of Chronic Kidney Disease on Platelet Reactivity and Outcomes of Patients Receiving Clopidogrel and Undergoing Percutaneous Coronary Intervention | 1.5 | 35 | Citations (PDF) |
| 232 | St. John’s Wort in Patients Non-responders to Clopidogrel Undergoing Percutaneous Coronary Intervention: a Single-Center Randomized Open-Label Trial (St. John’s Trial) | 1.3 | 9 | Citations (PDF) |
| 233 | VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice) | 0.7 | 211 | Citations (PDF) |
| 234 | Long-term clinical outcome after fractional flow reserve– versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts | 1.8 | 66 | Citations (PDF) |
| 235 | Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease | 0.4 | 14 | Citations (PDF) |
| 236 | Quantitative angiography and optical coherence tomography for the functional assessment of nonobstructive coronary stenoses: Comparison with fractional flow reserve | 1.8 | 40 | Citations (PDF) |
| 237 | Intracoronary Enalaprilat to Reduce Microvascular Damage During Percutaneous Coronary Intervention (ProMicro) Study | 0.7 | 58 | Citations (PDF) |
| 238 | Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention Without Acute Left Ventricular Ejection Fraction Impairment | 1.5 | 36 | Citations (PDF) |
| 239 | Efficacy of Clopidogrel Reloading in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention During Chronic Clopidogrel Therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] Trial) | 1.5 | 20 | Citations (PDF) |
| 240 | Association of Biomarkers of Lipid Modification with Functional and Morphological Indices of Coronary Stenosis Severity in Stable Coronary Artery Disease | 1.3 | 18 | Citations (PDF) |
| 241 | Novel Antiplatelet Agents: ALX-0081, a Nanobody Directed towards von Willebrand Factor | 1.3 | 85 | Citations (PDF) |
| 242 | Letter by Mangiacapra and Barbato Regarding Article, “Effects of Endothelial Dysfunction on Residual Platelet Aggregability After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery Disease” | 3.2 | 0 | Citations (PDF) |
| 243 | Fractional Flow Reserve–Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery | 13.1 | 187 | Citations (PDF) |
| 244 | In Vivo Flow Simulation at Coronary Bifurcation Reconstructed by Fusion of 3-Dimensional X-ray Angiography and Optical Coherence Tomography | 3.2 | 25 | Citations (PDF) |
| 245 | C2238 Atrial Natriuretic Peptide Molecular Variant Is Associated With Endothelial Damage and Dysfunction Through Natriuretic Peptide Receptor C Signaling | 8.6 | 36 | Citations (PDF) |
| 246 | Cost-Effectiveness of Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease and Abnormal Fractional Flow Reserve | 13.1 | 94 | Citations (PDF) |
| 247 | Synergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention | 1.1 | 13 | Citations (PDF) |
| 248 | Retrospective multicenter observational study of the interventional management of coronary disease in the very elderly: The NINETY | 1.1 | 10 | Citations (PDF) |
| 249 | Impact of negative lesion characteristics of chronic total occlusions on procedural outcome and strategy | 0.9 | 4 | Citations (PDF) |
| 250 | Quantitative angiography and optical coherence tomography for the functional assessment of mild-to-moderate coronary stenoses: comparison with fractional flow reserve | 2.6 | 0 | Citations (PDF) |
| 251 | Double-Blind Parallel Placebo-Controlled Study to Evaluate the Effect of Molsidomine on the Endothelial Dysfunction in Patients with Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention: the MEDCOR Trial | 1.3 | 3 | Citations (PDF) |
| 252 | Monocyte–Platelets Aggregates as Cellular Biomarker of Endothelium-Dependent Coronary Vasomotor Dysfunction in Patients with Coronary Artery Disease | 1.3 | 12 | Citations (PDF) |
| 253 | Chronic total occlusions for intermediate volume operators: An antegrade step-up algorithm allows high success in easy and intermediate difficult CTO lesions | 0.1 | 3 | Citations (PDF) |
| 254 | Influence of transradial versus transfemoral diagnostic heart catheterisation on peripheral vascular endothelial function | 2.2 | 17 | Citations (PDF) |
| 255 | Co-registration of fractional flow reserve and optical coherence tomography with the use of a three-dimensional angiographic roadmap: an opportunity for optimisation of complex percutaneous coronary interventions | 2.2 | 6 | Citations (PDF) |
| 256 | Individual Variability of Response to Antiplatelet Therapy is an Important Determinant of Adverse Clinical Outcome | 1.4 | 3 | Citations (PDF) |
| 257 | Pressure–Diameter Relationship in Human Coronary Arteries | 3.2 | 19 | Citations (PDF) |
| 258 | Long-Term Clinical Outcome After Fractional Flow Reserve–Guided Percutaneous Coronary Revascularization in Patients With Small-Vessel Disease | 3.2 | 85 | Citations (PDF) |
| 259 | High cholesterol levels are associated with coronary microvascular dysfunction | 0.9 | 21 | Citations (PDF) |
| 260 | Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease | 19.4 | 2,657 | Citations (PDF) |
| 261 | Comparison of drug-eluting versus bare-metal stents after rotational atherectomy for the treatment of calcified coronary lesions | 1.6 | 29 | Citations (PDF) |
| 262 | NT-proANP circulating level is a prognostic marker in stable ischemic heart disease | 1.6 | 18 | Citations (PDF) |
| 263 | Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study | 1.6 | 4 | Citations (PDF) |
| 264 | Influence of rs5065 Atrial Natriuretic Peptide Gene Variant on Coronary Artery Disease | 0.7 | 42 | Citations (PDF) |
| 265 | A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention | 1.9 | 87 | Citations (PDF) |
| 266 | Clinical Implications of Platelet—Vessel Interaction | 1.3 | 16 | Citations (PDF) |
| 267 | von Willebrand Factor Inhibition Improves Endothelial Function in Patients with Stable Angina | 1.3 | 24 | Citations (PDF) |
| 268 | Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction | 0.7 | 109 | Citations (PDF) |
| 269 | Long-Term Follow-Up After Fractional Flow Reserve–Guided Treatment Strategy in Patients With an Isolated Proximal Left Anterior Descending Coronary Artery Stenosis | 1.9 | 104 | Citations (PDF) |
| 270 | Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting | 1.8 | 25 | Citations (PDF) |
| 271 | Treatment of diabetic patients with non-ST-elevation myocardial infarction | 0.9 | 0 | Citations (PDF) |
| 272 | From SYNTAX to FAME, a paradigm shift in revascularization strategies | 0.9 | 19 | Citations (PDF) |
| 273 | Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel | 1.1 | 14 | Citations (PDF) |
| 274 | Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel | 1.1 | 33 | Citations (PDF) |
| 275 | Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction | 2.2 | 16 | Citations (PDF) |
| 276 | Effective Radiation Dose, Time, and Contrast Medium to Measure Fractional Flow Reserve | 1.9 | 43 | Citations (PDF) |
| 277 | Relation of Endothelial Function to Residual Platelet Reactivity After Clopidogrel in Patients With Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention | 1.5 | 36 | Citations (PDF) |
| 278 | Comparison of Platelet Reactivity and Periprocedural Outcomes in Patients With Versus Without Diabetes Mellitus and Treated With Clopidogrel and Percutaneous Coronary Intervention | 1.5 | 73 | Citations (PDF) |
| 279 | Comparison of 600 Versus 300-mg Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Angioplasty | 1.5 | 55 | Citations (PDF) |
| 280 | Thrombus aspiration in primary percutaneous coronary intervention in high‐risk patients with ST‐elevation myocardial infarction: A real‐world registry | 1.1 | 32 | Citations (PDF) |
| 281 | High Residual Platelet Reactivity After Clopidogrel | 1.9 | 68 | Citations (PDF) |
| 282 | Point-of-Care Assessment of Platelet Reactivity After Clopidogrel to Predict Myonecrosis in Patients Undergoing Percutaneous Coronary Intervention | 1.9 | 54 | Citations (PDF) |
| 283 | Fractional Flow Reserve for the Assessment of Nonculprit Coronary Artery Stenoses in Patients With Acute Myocardial Infarction | 1.9 | 316 | Citations (PDF) |
| 284 | Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome | 2.3 | 10 | Citations (PDF) |
| 285 | Residual Platelet Reactivity: Predicting Short- and Long-Term Clinical Outcome in Patients Undergoing Percutaneous Coronary Revascularization | 1.0 | 5 | Citations (PDF) |
| 286 | Biomarkers of Vulnerable Plaque: The Missing Link With Ischemia | 1.0 | 4 | Citations (PDF) |
| 287 | A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study | 2.2 | 45 | Citations (PDF) |
| 288 | Diastolic function and BNP changes during exercise predict oxygen consumption in chronic heart failure patients | 0.8 | 7 | Citations (PDF) |
| 289 | Long-Term Clinical Outcome After Fractional Flow Reserve–Guided Treatment in Patients With Angiographically Equivocal Left Main Coronary Artery Stenosis | 13.1 | 389 | Citations (PDF) |
| 290 | Human coronary atherosclerosis modulates cardiac natriuretic peptide release | 1.9 | 27 | Citations (PDF) |
| 291 | Relation of Low Response to Clopidogrel Assessed With Point-of-Care Assay to Periprocedural Myonecrosis in Patients Undergoing Elective Coronary Stenting for Stable Angina Pectoris | 1.5 | 65 | Citations (PDF) |
| 292 | Direct Stenting for Stable Angina Pectoris Is Associated With Reduced Periprocedural Microcirculatory Injury Compared With Stenting After Pre-Dilation | 0.7 | 86 | Citations (PDF) |
| 293 | In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction | 1.9 | 39 | Citations (PDF) |
| 294 | Role of adrenergic receptors in human coronary vasomotion | 2.6 | 54 | Citations (PDF) |
| 295 | Interference of Drug-Eluting Stents With Endothelium-Dependent Coronary Vasomotion | 3.2 | 98 | Citations (PDF) |
| 296 | GLU-27 variant of β2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease | 1.9 | 22 | Citations (PDF) |
| 297 | Assessment of Renal Flow and Flow Reserve in Humans | 0.7 | 68 | Citations (PDF) |
| 298 | Effect of Phentolamine on the Hyperemic Response to Adenosine in Patients With Microvascular Disease | 1.5 | 12 | Citations (PDF) |
| 299 | Role of β
2
Adrenergic Receptors in Human Atherosclerotic Coronary Arteries | 13.1 | 75 | Citations (PDF) |
| 300 | Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure | 2.6 | 185 | Citations (PDF) |
| 301 | Pressure-derived measurement of coronary flow reserve | 0.7 | 35 | Citations (PDF) |
| 302 | Validation of coronary flow reserve measurements by thermodilution in clinical practice | 2.6 | 166 | Citations (PDF) |
| 303 | Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses | 2.6 | 21 | Citations (PDF) |
| 304 | Tissue doppler imaging predicts recovery of left ventricular function after recanalization of an occluded coronary artery | 0.7 | 34 | Citations (PDF) |
| 305 | Effects of intravenous dobutamineon coronary vasomotion in humans | 0.7 | 48 | Citations (PDF) |
| 306 | Intracoronary and Intravenous Adenosine 5′-Triphosphate, Adenosine, Papaverine, and Contrast Medium to Assess Fractional Flow Reserve in Humans | 13.1 | 328 | Citations (PDF) |
| 307 | Direct stenting | 2.6 | 59 | Citations (PDF) |
| 308 | P1580 Beta 2 adrenergic GIn27Glu polymorphism is a protective factor for left-ventricular dysfunction | 2.6 | 0 | Citations (PDF) |
| 309 | 162 Human cardiac performance is genetically modulated by ile-164 polymorphism of beta-2 adrenergic receptor | 2.6 | 0 | Citations (PDF) |
| 310 | 745 Coronary vasomotion during dobutamine stress testing in patients with coronary artery disease | 2.6 | 0 | Citations (PDF) |
| 311 | P3313 Human beta2-adrenergic receptors response at both macro and micro circulatory level is impaired in severe coronary atherosclerosis | 2.6 | 0 | Citations (PDF) |
| 312 | Coronary Thermodilution to Assess Flow Reserve | 13.1 | 330 | Citations (PDF) |
| 313 | ROLE OF THE SYMPATHETIC NERVOUS SYSTEM IN CARDIAC REMODELING IN HYPERTENSION | 3.7 | 11 | Citations (PDF) |
| 314 | Effects of nitrendipine on plasma levels of insulin and glucose in patients with essential hypertension | 1.6 | 4 | Citations (PDF) |
| 315 | Insulin Enhances Endothelial α2-Adrenergic Vasorelaxation by a Pertussis Toxin Mechanism | 4.7 | 38 | Citations (PDF) |
| 316 | Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. | 6.8 | 69 | Citations (PDF) |
| 317 | Multivessel disease in patient with acute myocardial infarction: current treatment strategies and future perspectives | 1.0 | 1 | Citations (PDF) |
| 318 | Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis | 2.6 | 13 | Citations (PDF) |
| 319 | Atlas of interventional cardiology 2023: European Society of Cardiology and European Association of Percutaneous Coronary Interventions | 2.6 | 4 | Citations (PDF) |
| 320 | Very low-calorie ketogenic diet reduces left ventricular mass and epicardial adipose tissue in post-menopausal women with essential hypertension and obesity: A single-center, prospective, open-label, clinical study | 2.2 | 2 | Citations (PDF) |
| 321 | Glucagon-like peptide-1 receptor agonists and the endothelium: molecular and clinical insights into cardiovascular protection | 1.7 | 23 | Citations (PDF) |
| 322 | Addressing Evidence and Gaps in Knowledge in Extracellular Volume for Patients Undergoing Transcatheter Aortic Valve Implantation | 1.5 | 0 | Citations (PDF) |
| 323 | Reclassification of patients with normal blood pressure levels after 2024 European society of cardiology guidelines on hypertension | 1.4 | 1 | Citations (PDF) |
| 324 | Complete Revascularization in Older Patients With Myocardial Infarction With or Without Complex Nonculprit Lesions | 3.2 | 1 | Citations (PDF) |
| 325 | Anatomical approach for left parahisian ventricular arrhythmia ablation to reduce atrioventricular block risk | 0.3 | 0 | Citations (PDF) |
| 326 | Vessel‐Specific Myocardial Mass in Patients With Stable Coronary Artery Disease | 3.1 | 5 | Citations (PDF) |
| 327 | Bridging the Gap: Exploring Right Ventricular-Pulmonary Artery Coupling in Acute Coronary syndrome–A Pilot Study | 1.4 | 1 | Citations (PDF) |
| 328 | Computed tomography angiography-derived microvascular resistance: is less always more? | 2.2 | 0 | Citations (PDF) |
| 329 | Analysis of office and out-of-office blood pressure levels in adult outpatients with hypertensive urgency: a cross-sectional, retrospective study in a hypertension excellence center | 1.4 | 0 | Citations (PDF) |
| 330 | The year in cardiovascular medicine 2025: the top 10 papers in interventional cardiology | 2.6 | 2 | Citations (PDF) |
| 331 | Diagnostic Performance of Non‐Hyperemic Pressure Ratios Versus Fractional Flow Reserve Stratified by Coronary Artery: A Systematic Review and Meta‐Analysis of Individual Patient Data | 3.1 | 1 | Citations (PDF) |
| 332 | Great debate: drug-coated balloons are preferable to drug-eluting stents for coronary in-stent restenosis | 2.6 | 5 | Citations (PDF) |
| 333 | Lipoprotein(a) in Essential Hypertension: Associations with Blood Pressure and Hypertension-Mediated Organ Damage | 1.4 | 1 | Citations (PDF) |
| 334 | Hypertension Treatment with Angiotensin Receptor Blockers and Other Antihypertensive Agents: A Real-World Registry from a High-Volume Specialized Center Over TwoDecades | 1.4 | 0 | Citations (PDF) |
| 335 | Full-on commitment to interventional cardiology – today and in the future | 2.2 | 0 | Citations (PDF) |
| 336 | Serum Uric Acid as a Cardiovascular Risk Marker: Differential Effects of Ketogenic Diet and Intermittent Fasting in Postmenopausal Women | 3.2 | 0 | Citations (PDF) |
| 337 | To reload or not to reload? Reassessing clopidogrel strategy after percutaneous coronary intervention in stable coronary disease | 0.9 | 1 | Citations (PDF) |
| 338 | To crack or to ablate? The contemporary calcium dilemma | 2.2 | 0 | Citations (PDF) |
| 339 | Formazione universitaria e post-universitaria in cardiologia: una responsabilità strategica per il futuro della medicina cardiovascolare italiana | 0.0 | 0 | Citations (PDF) |
| 340 | L’importanza della comunicazione | 0.0 | 0 | Citations (PDF) |
